LATE HEMORRHAGIC CYSTITIS FOLLOWING LOW-DOSE CYCLOPHOSPHAMIDE THERAPY

被引：11

作者：

MARSHALL, FF ^{[1
]}

KLINEFELTER, HF ^{[1
]}

机构：

[1] JAMES BUCHANAN BRADY UROL INST,BALTIMORE,MD

来源：

UROLOGY | 1979年 / 14卷 / 06期

关键词：

D O I：

10.1016/0090-4295(79)90526-0

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Hemorrhagic cystitis is a recognized acute complication of cyclophosphamide (Cytoxan) therapy in the treatment of malignant disease. More recently, lower dose, long-term cyclophosphamide therapy has been used in the treatment of autoimmune diseases including rheumatoid arthritis. In 3 patients hemorrhagic cystitis developed after long-term cyclophosphamide therapy for rheumatoid arthritis. Even in low dosage, this drug may cause hemorrhagic cystitis. © 1979.

引用

页码：573 / 575

页数：3

共 14 条

[1]

COGGINS PETER R., 1959, CANCER CHEMOTHERAPY REPTS, V3, P9

[2]

DECKER JL, 1975, ANN INTERN MED, V83, P600

[3] SEVERE CYCLOPHOSPHAMIDE HEMORRHAGIC CYSTITIS CONTROLLED WITH PHENOL [J].